» Articles » PMID: 31548242

Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry

Abstract

Objective: We sought to determine the prevalence of diabetes and associated cardiovascular outcomes in a contemporary cohort of young individuals presenting with their first myocardial infarction (MI) at age ≤50 years.

Research Design And Methods: We retrospectively analyzed records of patients presenting with a first type 1 MI at age ≤50 years from 2000 to 2016. Diabetes was defined as a hemoglobin A ≥6.5% (48 mmol/mol) or a documented diagnosis of or treatment for diabetes. Vital status was ascertained for all patients, and cause of death was adjudicated.

Results: Among 2,097 young patients who had a type 1 MI (mean age 44.0 ± 5.1 years, 19.3% female, 73% white), diabetes was present in 416 (20%), of whom 172 (41%) were receiving insulin. Over a median follow-up of 11.2 years (interquartile range 7.3-14.2 years), diabetes was associated with a higher all-cause mortality (hazard ratio 2.30; < 0.001) and cardiovascular mortality (2.68; < 0.001). These associations persisted after adjusting for baseline covariates (all-cause mortality: 1.65; = 0.008; cardiovascular mortality: 2.10; = 0.004).

Conclusions: Diabetes was present in 20% of patients who presented with their first MI at age ≤50 years and was associated with worse long-term all-cause and cardiovascular mortality. These findings highlight the need for implementing more aggressive therapies aimed at preventing future adverse cardiovascular events in this population.

Citing Articles

A retrospective study of the association between serum uric acid and risk of coronary heart disease complicated with different types of chronic heart failure.

Yu L, Sun J, Liu X Eur J Med Res. 2025; 30(1):146.

PMID: 40022200 PMC: 11871693. DOI: 10.1186/s40001-025-02403-y.


Traditional and non-traditional cardiovascular risk factor profiles in young patients with coronary artery disease.

Adhikari A, DeJesus S, Swe N, Vaidean G, Nahrwold R, Joshua J Am Heart J Plus. 2024; 47:100471.

PMID: 39473786 PMC: 11513663. DOI: 10.1016/j.ahjo.2024.100471.


Intermediate Hyperglycemia Increases the Risk of All-Cause Mortality in Premature Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention.

Zhou Z, Qiao L, Ling Y, He Y, Chang T, Lu H Rev Cardiovasc Med. 2024; 24(12):352.

PMID: 39077077 PMC: 11272885. DOI: 10.31083/j.rcm2412352.


Young hearts at risk: Unveiling novel factors in myocardial infarction susceptibility and prevention.

Ranjan A, Agarwal R, Mudgal S, Bhattacharya S, Kumar B J Family Med Prim Care. 2024; 13(4):1200-1205.

PMID: 38827682 PMC: 11141995. DOI: 10.4103/jfmpc.jfmpc_1639_23.


Uric acid and evaluate the coronary vascular stenosis gensini score correlation research and in gender differences.

Yang B, Ma K, Xiang R, Yang G, Luo Y, Wu F BMC Cardiovasc Disord. 2023; 23(1):546.

PMID: 37940848 PMC: 10634079. DOI: 10.1186/s12872-023-03581-5.


References
1.
Wiviott S, Raz I, Bonaca M, Mosenzon O, Kato E, Cahn A . Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018; 380(4):347-357. DOI: 10.1056/NEJMoa1812389. View

2.
Mayer-Davis E, Lawrence J, Dabelea D, Divers J, Isom S, Dolan L . Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med. 2017; 376(15):1419-1429. PMC: 5592722. DOI: 10.1056/NEJMoa1610187. View

3.
Das S, Everett B, Birtcher K, Brown J, Cefalu W, Januzzi Jr J . 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert.... J Am Coll Cardiol. 2018; 72(24):3200-3223. PMC: 7560953. DOI: 10.1016/j.jacc.2018.09.020. View

4.
Marso S, Daniels G, Brown-Frandsen K, Kristensen P, Mann J, Nauck M . Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016; 375(4):311-22. PMC: 4985288. DOI: 10.1056/NEJMoa1603827. View

5.
Rhodes E, Prosser L, Hoerger T, Lieu T, Ludwig D, Laffel L . Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet Med. 2011; 29(4):453-63. DOI: 10.1111/j.1464-5491.2011.03542.x. View